Cargando…
Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios
Sperm DNA fragmentation (SDF) has been generally acknowledged as a valuable tool for male fertility evaluation. While its detrimental implications on sperm function were extensively investigated, little is known about the actual indications for performing SDF analysis. This review delivers practice...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182232/ https://www.ncbi.nlm.nih.gov/pubmed/28078226 http://dx.doi.org/10.21037/tau.2016.10.03 |
_version_ | 1782485829177835520 |
---|---|
author | Agarwal, Ashok Majzoub, Ahmad Esteves, Sandro C. Ko, Edmund Ramasamy, Ranjith Zini, Armand |
author_facet | Agarwal, Ashok Majzoub, Ahmad Esteves, Sandro C. Ko, Edmund Ramasamy, Ranjith Zini, Armand |
author_sort | Agarwal, Ashok |
collection | PubMed |
description | Sperm DNA fragmentation (SDF) has been generally acknowledged as a valuable tool for male fertility evaluation. While its detrimental implications on sperm function were extensively investigated, little is known about the actual indications for performing SDF analysis. This review delivers practice based recommendations on commonly encountered scenarios in the clinic. An illustrative description of the different SDF measurement techniques is presented. SDF testing is recommended in patients with clinical varicocele and borderline to normal semen parameters as it can better select varicocelectomy candidates. High SDF is also linked with recurrent spontaneous abortion (RSA) and can influence outcomes of different assisted reproductive techniques. Several studies have shown some benefit in using testicular sperm rather than ejaculated sperm in men with high SDF, oligozoospermia or recurrent in vitro fertilization (IVF) failure. Infertile men with evidence of exposure to pollutants can benefit from sperm DNA testing as it can help reinforce the importance of lifestyle modification (e.g., cessation of cigarette smoking, antioxidant therapy), predict fertility and monitor the patient’s response to intervention. |
format | Online Article Text |
id | pubmed-5182232 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-51822322017-01-11 Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios Agarwal, Ashok Majzoub, Ahmad Esteves, Sandro C. Ko, Edmund Ramasamy, Ranjith Zini, Armand Transl Androl Urol Guideline Sperm DNA fragmentation (SDF) has been generally acknowledged as a valuable tool for male fertility evaluation. While its detrimental implications on sperm function were extensively investigated, little is known about the actual indications for performing SDF analysis. This review delivers practice based recommendations on commonly encountered scenarios in the clinic. An illustrative description of the different SDF measurement techniques is presented. SDF testing is recommended in patients with clinical varicocele and borderline to normal semen parameters as it can better select varicocelectomy candidates. High SDF is also linked with recurrent spontaneous abortion (RSA) and can influence outcomes of different assisted reproductive techniques. Several studies have shown some benefit in using testicular sperm rather than ejaculated sperm in men with high SDF, oligozoospermia or recurrent in vitro fertilization (IVF) failure. Infertile men with evidence of exposure to pollutants can benefit from sperm DNA testing as it can help reinforce the importance of lifestyle modification (e.g., cessation of cigarette smoking, antioxidant therapy), predict fertility and monitor the patient’s response to intervention. AME Publishing Company 2016-12 /pmc/articles/PMC5182232/ /pubmed/28078226 http://dx.doi.org/10.21037/tau.2016.10.03 Text en 2016 Translational Andrology and Urology. All rights reserved. |
spellingShingle | Guideline Agarwal, Ashok Majzoub, Ahmad Esteves, Sandro C. Ko, Edmund Ramasamy, Ranjith Zini, Armand Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios |
title | Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios |
title_full | Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios |
title_fullStr | Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios |
title_full_unstemmed | Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios |
title_short | Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios |
title_sort | clinical utility of sperm dna fragmentation testing: practice recommendations based on clinical scenarios |
topic | Guideline |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182232/ https://www.ncbi.nlm.nih.gov/pubmed/28078226 http://dx.doi.org/10.21037/tau.2016.10.03 |
work_keys_str_mv | AT agarwalashok clinicalutilityofspermdnafragmentationtestingpracticerecommendationsbasedonclinicalscenarios AT majzoubahmad clinicalutilityofspermdnafragmentationtestingpracticerecommendationsbasedonclinicalscenarios AT estevessandroc clinicalutilityofspermdnafragmentationtestingpracticerecommendationsbasedonclinicalscenarios AT koedmund clinicalutilityofspermdnafragmentationtestingpracticerecommendationsbasedonclinicalscenarios AT ramasamyranjith clinicalutilityofspermdnafragmentationtestingpracticerecommendationsbasedonclinicalscenarios AT ziniarmand clinicalutilityofspermdnafragmentationtestingpracticerecommendationsbasedonclinicalscenarios |